人工胰腺系统对1型糖尿病未预告与预告运动的碳水化合物建议性能评估
该随机三臂交叉试验在10例1型糖尿病成人中比较了多变量闭环(MCL)控制器在未预告(CLNA)和预告(CLA)运动下与开环治疗(OL)的安全性和性能。MCL两种模式均降低了运动期间及运动后3小时传感器葡萄糖<70 mg/dL的时间比例(CLNA 0.0% vs OL 16.2%,P=0.047;CLA 0.0% vs OL 16.2%,P=0.063)并增加了70-180 mg/dL时间比例(CLA 91.9% vs OL 81.1%,P=0.039),且胰岛素剂量相似、碳水化合物摄入减少。
要点
- MCL系统在未预告和预告运动期间及运动后3小时均表现良好且安全。
- CLNA组传感器葡萄糖<70 mg/dL时间比例为0.0% vs OL组16.2%(P=0.047)。
- CLA组70-180 mg/dL时间比例为91.9% vs OL组81.1%(P=0.039)。
核心结论
- 带自动碳水化合物建议的MCL系统在未预告和预告运动期间及运动后表现良好且安全,大部分时间维持血糖在目标范围内,并在碳水化合物摄入减少的情况下降低低血糖风险。
研究设计与样本
- 随机三臂交叉临床试验,纳入10例使用胰岛素泵、HbA1c在6.0%至8.5%之间的1型糖尿病成人,按随机顺序比较MCL未预告运动(CLNA)、MCL预告运动(CLA)与开环治疗(OL)。
- 参与者完成重强度有氧运动,包括3组15分钟功率自行车运动,组间休息5分钟;评估运动期间及运动后3小时的血糖控制。
主要发现
- 传感器葡萄糖<70 mg/dL的时间比例:CLNA组0.0%(10-90百分位0.0-16.8)vs OL组16.2%(0.0-26.0),P=0.047;CLA组0.0%(0.0-19.2)vs OL组16.2%(0.0-26.0),P=0.063。
- 低血糖事件数:CLNA组4次、CLA组3次 vs OL组8次,P=0.218、P=0.250。
- 70-180 mg/dL时间比例:CLNA组87.8%(51.1-100)vs OL组81.1%(65.4-87.0),P=0.227;CLA组91.9%(58.7-100)vs OL组81.1%(65.4-87.0),P=0.039。
- MCL系统以相似胰岛素剂量和减少的碳水化合物摄入量实现上述血糖控制。
临床怎么用
- 作者结论认为带自动碳水化合物建议的MCL系统在未预告和预告运动期间及运动后表现良好且安全。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the safety and performance of a new multivariable closed-loop (MCL) glucose controller with automatic carbohydrate recommendation during and after unannounced and announced exercise in adults with type 1 diabetes (T1D). RESEARCH DESIGN AND METHODS: A randomized, 3-arm, crossover clinical trial was conducted. Participants completed a heavy aerobic exercise session including three 15-minute sets on a cycle ergometer with 5 minutes rest in between. In a randomly determined order, we compared MCL control with unannounced (CLNA) and announced (CLA) exercise to open-loop therapy (OL). Adults with T1D, insulin pump users, and those with hemoglobin (Hb)A1c between 6.0% and 8.5% were eligible. We investigated glucose control during and 3 hours after exercise. RESULTS: Ten participants (aged 40.8 ± 7.0 years; HbA1c of 7.3 ± 0.8%) participated. The use of the MCL in both closed-loop arms decreased the time spent <70 mg/dL of sensor glucose (0.0%, [0.0-16.8] and 0.0%, [0.0-19.2] vs 16.2%, [0.0-26.0], (%, [percentile 10-90]) CLNA and CLA vs OL respectively; P = 0.047, P = 0.063) and the number of hypoglycemic events when compared with OL (CLNA 4 and CLA 3 vs OL 8; P = 0.218, P = 0.250). The use of the MCL system increased the proportion of time within 70 to 180 mg/dL (87.8%, [51.1-100] and 91.9%, [58.7-100] vs 81.1%, [65.4-87.0], (%, [percentile 10-90]) CLNA and CLA vs OL respectively; P = 0.227, P = 0.039). This was achieved with the administration of similar doses of insulin and a reduced amount of carbohydrates. CONCLUSIONS: The MCL with automatic carbohydrate recommendation performed well and was safe during and after both unannounced and announced exercise, maintaining glucose mostly within the target range and reducing the risk of hypoglycemia despite a reduced amount of carbohydrate intake.Register Clinicaltrials.gov: NCT03577158.
引用
- Viñals C, Beneyto A, Martín-SanJosé JF, et al. Artificial Pancreas With Carbohydrate Suggestion Performance for Unannounced and Announced Exercise in Type 1 Diabetes. J Clin Endocrinol Metab. 2021. PMID: 32852548. doi:10.1210/clinem/dgaa562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。